Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor

By van de Lagemaat R.   Timmers C.M.   Kelder J.   van Koppen C.   Mosselman S.   Hanssen R.G.J.M.  

Human Reproduction, Vol. 24, Iss. 3, 2009-03 ,pp. : 640-648

Oxford University Press

Access to resources Recommend Favorite

Association of the luteinizing hormone/choriogonadotropin receptor gene polymorphism with polycystic ovary syndrome

By Bassiouny Yasmin Ahmed   Rabie Walaa Ahmed   Hassan Ayman Ahmed   Darwish Rania Kamal  

Gynecological Endocrinology, Vol. 30, Iss. 6, 2014-06 ,pp. : 428-430

Informa Healthcare

Access to resources Recommend Favorite

Genetics and genetic diagnosis. Association of molecular variants of luteinizing hormone with male infertility

By Ramanujam L.N.   Liao W.-X.   Roy A.C.  

Human Reproduction, Vol. 15, Iss. 4, 2000-04 ,pp. : 925-928

Oxford University Press

Access to resources Recommend Favorite

Effect of δ-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women

By Bondanelli M  

Human Reproduction, Vol. 13, Iss. 5, 1998-05 ,pp. : 1159-1162

Oxford University Press

Access to resources Recommend Favorite

Regulation of follicle-stimulating and luteinizing hormone receptor signaling by “regulator of G protein signaling” proteins

By Castro-Fernández C.   Maya-Núñez G.   Méndez J.  

Endocrine Journal, Vol. 25, Iss. 1, 2004-10 ,pp. : 49-54

Humana Press, Inc

Access to resources Recommend Favorite